Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
Peeters
Marc
M
University Hospital Ghent, Ghent, Belgium. Marc.Peeters@uza.be
Price
Timothy Jay
TJ
Cervantes
Andrés
A
Sobrero
Alberto F
AF
Ducreux
Michel
M
Hotko
Yevhen
Y
André
Thierry
T
Chan
Emily
E
Lordick
Florian
F
Punt
Cornelis J A
CJ
Strickland
Andrew H
AH
Wilson
Gregory
G
Ciuleanu
Tudor-Eliade
TE
Roman
Laslo
L
Van Cutsem
Eric
E
Tzekova
Valentina
V
Collins
Simon
S
Oliner
Kelly S
KS
Rong
Alan
A
Gansert
Jennifer
J